Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 4/20 | 0.41 |
| ▸ | CNR1 | P21554 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | AKT1 | P31749 | 1/20 | 0.33 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.32 |
| ▸ | BAD | Q92934 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31544945 | 0.79 | CNR2 (0.67) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL31546045 | 0.79 | CNR2 (0.54) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL11776536 | 0.71 | CNR2 (0.57) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL6824008 | 0.70 | CA1 (0.42) | MEN1GAAKMT2AIDO1 | |
| SCHEMBL11737119 | 0.70 | CNR2 (0.71) | CNR2CNR1 | |
| SCHEMBL31544847 | 0.70 | CNR2 (0.71) | CNR2CNR1 | |
| SCHEMBL10847855 | 0.70 | KDM4E (0.47) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL11151388 | 0.69 | TRPA1 (0.36) | CNR2CNR1MEN1KMT2AAKT1 | |
| Hydrochloric Acid SCHEMBL10507864 | 0.69 | ADRB2 (0.48) | MEN1KMT2A | |
| SCHEMBL11774583 | 0.69 | CNR2 (0.56) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |